These data suggest that hyperactivated ERK-mediated suppression of NE factors in SCLC might be dependent on altered chromatin structures, which vary depending on the subtype of SCLC defined based on the corresponding master regulator, ASCL1 or NEUROD1. The gene discussed is NEUROD1; the disease is small cell lung carcinoma.